News

Aquaculture Vaccines Market (By Product: Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines; By Route Of Administration: Oral, Injected, Immersion & Spray; By Application: Bacterial, Viral, Parasitic) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

The global aquaculture vaccines market size is expected to be worth around US$ 706.2 million by 2030, according to a new report by Vision Research Reports.

The global aquaculture vaccines market size was valued at US$ 352.4 million in 2020 and is anticipated to grow at a CAGR of 13.4% during forecast period 2021 to 2030.

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38535

Report Coverage

Report Scope	Details
Market Size	USD 7.06.2 Mn by 2030
Growth Rate	CAGR of 13.4% From 2021 to 2030
Base Year	2020
Historic Data	2017 to 2020
Forecast Period	2021 to 2030
Segments Covered	Product, Route of administration, Application
Regional Scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned	Zoetis; Phibro Animal Health Corporation; Elanco; Merck & Co., Inc.; KBNP; CAVAC; Kyoto Biken Laboratories, Inc.; Nisseiken Co., Ltd.; Vaxxinova International BV; HIPRA

Growth Factors

 The growing demand for aquatic animal-derived food products, such as oil, caviar, protein powders, and meat, is encouraging farmers to use vaccinations for to gain higher profitability. Due to the rising urbanization, consumers are becoming more aware of the nutritious value of animal protein. The demand for healthy, sustainable, aquaculture vaccines and high-quality meat products that have fewer or no drugs is also increasing rapidly. Thus, the need for healthy breeding of aquatic animals is increasing, which is expected to fuel the demand for aquaculture vaccines, thereby boosting the market growth.

Key Players

• Zoetis
• Phibro Animal Health Corporation
• Elanco
• Merck & Co., Inc.
• KBNP
• CAVAC
• Kyoto Biken Laboratories, Inc.
• Nisseiken Co., Ltd.
• Vaxxinova International BV
• HIPRA

Market Segmentation

• Product
  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
• Route Of Administration
  • Oral
  • Injected
  • Immersion & Spray
• Application
  • Bacterial
  • Viral
  • Parasitic
• Regional
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Ireland
    • Eastern Europe
      • Croatia
      • Czech Republic
      • Hungary
      • Poland
      • Russia
      • Romania
      • Bulgaria
  • Asia Pacific
    • Japan
    • South Korea
    • Taiwan
    • Indonesia
    • Malaysia
    • Singapore
    • Thailand
    • Philippines
    • Vietnam
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Colombia
    • Peru
    • Ecuador
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Israel
    • Egypt

Buy This Premium Research Report, click here@https://www.visionresearchreports.com/report/cart/38535 or call: +1 9197 992 333